The Joint swings to Q2 FY26 profit of $653,000; revenue rises 14% to $15.2 million
Reuters2026/08/06 20:19- The Joint Corp. posted Q2 net income of $653,000, up from $93,000 a year earlier, as revenue rose 14% to $15.2 million.
- Adjusted EBITDA (non-GAAP) from continuing operations rose to $1.5 million from $88,000, while cash flow from operating activities more than doubled to $2.2 million.
- System-wide sales fell 3.7% to $180 million, while comp sales improved 140 basis points versus Q1 to -2.8%.
- Clinic count totaled 941 at June 30; the company opened five clinics, closed seven, and refranchised 29 during the quarter.
- Reiterated 2026 guidance for system-wide sales of $519 million-$552 million, consolidated adjusted EBITDA (non-GAAP) of $12.5 million-$13.5 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The rebound of the yen may only be temporary, Morgan Stanley bets on arbitrage trades making a comeback, USD/JPY expected to rise to 163.
Morgan Stanley believes that the recent strengthening of the Japanese yen is mainly due to the unwinding of short-term arbitrage trades and market bets on Japanese capital repatriation, rather than any substantial improvement in fundamentals.

Control Empresarial de Capitales reports $24.63 million PBF Energy common share sale
Cytokinetics director Robert E. Landry sells 1,000 common shares worth $74,660
DocuSign director Peter Solvik disposes of USD 3,004,020 in common shares